Interestingly, the current study found a definite upregulation of both CST1 and CST2 in CRC tissues, while higher CST2 expression in CRC tissues was correlated with advanced clinical stages and shorter DFS in patients with CRC. This evidence concerns the gene CST1 and colorectal carcinoma.